We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
…. and the Arcturis website has had ‘full website coming soon’ since around the middle of November.
Huma have still made no mention of their acquisition from Arcturus. Yet they happy to release this
https://www.prnewswire.co.uk/news-releases/huma-to-provide-best-in-class-digital-clinical-trials-solutions-through-landmark-acquisition-of-alcedis-301715943.html
Still suspect some ongoing negotiations for corporate action.
Still a waiting game. Accounts still not published at Companies House for year ending Apr 22. . No info anywhere from the divestment even the purchaser has made No statement and this month the loans notes are due to be settled. Website still displays ‘more soon ‘
If you don’t trade in OTC market then what are your options if holding?
Damn for a second i thought i got lucky! I have a feeling tho it will relist but over a years time
Yes, my bad. I glanced at it and thought it’s coming back on the market. I’ve written this off so was surprised to receive a notification. Who knows, we may still get a return on this
That's just the name change, which was sent a while ago - nothing to suggest relisting anytime soon.
Sorry, nothing about relisting yet but this seems positive
SENSYNE HEALTH PLC - Name Change
Name Change.
The new name of the Company is Arcturis Data (UK) Ltd.
Your new holding is 40000 ARCTURIS DATA ORD GBP0.10 shares.
Following our communication of 30th May 2022, we have received information that Sensyne Health have changed their name to Arcturis Data (UK) Ltd. We can confirm that your account has been updated accordingly.
Should you retain your holding, we will notify you on receipt of any further information from the Company.
Should you wish to find more information about the Name Change, please visit Arcturis Data's website.
Im with HL and I've not had anything come through yet - what did the message say?
Check in your cooperate actions, it’s going to be relisted as arcturis
what did the message say and who was it from?
Anyone else received a message that it will be back on the market?
Arcturis have job openings for an Epidemiologist, Senior Epidemiologist and a Medical Statistician.
They do appear to be progressing in the right direction behind the scences and who knows, this bottom draw investment could actually pay off one day.
https://www.linkedin.com/company/arcturis-data/
What about monies received from the Huma deal. There is nothing published anywhere about this deal other than on the old Sensyne website.
The Website has now been up for 4 weeks. With ‘ more to come soon ‘ statement.
Finally full accounts for year ending Ape 22 when still a public Co not yet published at Companies House.
There is more to come, mark my words.
Great stuff, good to know that things are progressing well behind the scenes. Thanks for sharing.
Nice! Thanks for sharing. See you all in 2025, then :-D
Thanks. Looks like Things are progressing well. Alex Snow is on a mission
https://news.sky.com/story/chief-of-reborn-sensyne-health-secures-funding-for-growth-plan-12767384
https://www.evaluate.com/vantage/articles/news/deals-snippets/csl-stops-short-buying-arcturus
Completely as a side issue and linking Arcturus Therapeutics with Arcturis Data is tenuous at best on just the basis of similarity of name. . One wonders why Though CSL held off buying outright. . Arcturus have also been on Merck’s radar
https://www.gurufocus.com/news/1540025/biogen-mirati-and-arcturus-reportedly-on-mercks-radar